Wayland Group Corp.
Wayland Group Corp. (MRRCF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mrrcf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Wayland Group Corp.You MRRCF | $0M | N/A | — | -$0.75 |
 Aeolus Pharmaceuticals, Inc. AOLS | $0M | N/A | — | -$0.02 |
 The CannaBusiness Group, Inc. CBGI | $0M | N/A | — | -$1.98 |
 Cannonau Corp. CNNC | $0M | 0.11x | — | $0.14 |
 Fiore Cannabis Ltd. FIORF | $0M | N/A | — | -$0.06 |
 Filament Health Corp. FLHLF | $0M | N/A | — | -$0.02 |
 Halo Collective Inc. HCANF | $0M | N/A | — | -$10.55 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Wayland Group Corp. (MRRCF) measures how much investors pay for each dollar of the company's trailing earnings. MRRCF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.75.
Frequently asked questions
MRRCF pe ratio · 6 questionsMRRCF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.75. Data sourced from Financial Modeling Prep via MRRCF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Wayland Group Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09